MUC1-C oncoprotein induces TCF7L2 transcription factor activation and promotes cyclin D1 expression in human breast cancer cells

Journal of Biological Chemistry

Volumn 287, Issue 13, 2012, Pages 10703-10713

  Rajabi, Hasan ^a   Ahmad, Rehan ^a   Jin, Caining ^a   Kosugi, Michio ^a   Alam, Maroof ^a   Joshi, Maya Datt ^a   Kufe, Donald ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; BREAST CANCER CELLS; C-TERMINAL REGIONS; C-TERMINAL-BINDING PROTEINS; CYCLIND1; CYTOPLASMIC DOMAINS; GENE PROMOTER; HUMAN BREAST CANCER CELLS; MEDIATED TRANSCRIPTION; ONCOPROTEINS;

CELLS; GENES; TRANSCRIPTION FACTORS;

TRANSCRIPTION;

BETA CATENIN; BINDING PROTEIN; C TERMINAL BINDING PROTEIN; CYCLIN D1; HISTONE H3; MUCIN 1; TRANSCRIPTION FACTOR 7 LIKE 2; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL CULTURE; CARBOXY TERMINAL SEQUENCE; COMPLEX FORMATION; CONTROLLED STUDY; CYCLIN D1 GENE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE SILENCING; HISTONE ACETYLATION; HUMAN; HUMAN CELL; ONCOGENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS INHIBITION; TRANSCRIPTION INITIATION;

ALCOHOL OXIDOREDUCTASES; BETA CATENIN; BREAST NEOPLASMS; CELL LINE, TUMOR; CYCLIN D1; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MUCIN-1; P300-CBP TRANSCRIPTION FACTORS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; TRANSCRIPTION FACTOR 7-LIKE 2 PROTEIN; TRANSCRIPTION, GENETIC;

EID: 84858994452     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.323311     Document Type: Article

References (44)

1. Polakis, P. (2007) The many ways of Wnt in cancer. Curr. Opin. Genet. Dev. 17, 45-51
2. Reya, T., and Clevers, H. (2005) Wnt signaling in stem cells and cancer. Nature 434, 843-850 (Pubitemid 40558990)
3. Hoppler, S., and Kavanagh, C. L. (2007) Wnt signaling: Variety at the core. J. Cell Sci. 120, 385-393
4. MacDonald, B. T., Tamai, K., and He, X. (2009) Wnt/β-catenin signaling: Components, mechanisms, and diseases. Dev. Cell 17, 9-26
5. Daniels, D. L., and Weis, W. I. (2005) β-Catenin directly displaces Groucho/TLE repressors from Tcf/Lef in Wnt-mediated transcription activation. Nat. Struct. Mol. Biol. 12, 364-371 (Pubitemid 43093092)
6. Atcha, F. A., Munguia, J. E., Li, T. W., Hovanes, K., and Waterman, M. L. (2003) A new β-catenin-dependent activation domain in T cell factor. J. Biol. Chem. 278, 16169-16175 (Pubitemid 36799739)
7. Atcha, F. A., Syed, A., Wu, B., Hoverter, N. P., Yokoyama, N. N., Ting, J. H., Munguia, J. E., Mangalam, H. J., Marsh, J. L., and Waterman, M. L. (2007) A unique DNA binding domain converts T-cell factors into strong Wnt effectors. Mol. Cell. Biol. 27, 8352-8363 (Pubitemid 350234246)
8. Weise, A., Bruser, K., Elfert, S., Wallmen, B., Wittel, Y., Wöhrle, S., and Hecht, A. (2010) Alternative splicing of Tcf7l2 transcripts generates protein variants with differential promoter-binding and transcriptional activation properties at Wnt/β-catenin targets. Nucleic Acids Res. 38, 1964-1981
9. van de Wetering, M., Cavallo, R., Dooijes, D., van Beest, M., van Es, J., Loureiro, J., Ypma, A., Hursh, D., Jones, T., Bejsovec, A., Peifer, M., Mortin, M., and Clevers, H. (1997) Armadillo coactivates transcription driven by the product of the Drosophila segment polarity gene dTCF. Cell 88, 789-799 (Pubitemid 27164267)
10. Hecht, A., and Stemmler, M. P. (2003) Identification of a promoter-specific transcriptional activation domain at the C terminus of the Wnt effector protein T-cell factor 4. J. Biol. Chem. 278, 3776-3785 (Pubitemid 36801104)
11. Cuilliere-Dartigues, P., El-Bchiri, J., Krimi, A., Buhard, O., Fontanges, P., Fléjou, J. F., Hamelin, R., and Duval, A. (2006) TCF4 isoforms absent in TCF4 mutated MSI-H colorectal cancer cells colocalize with nuclear CtBP and repress TCF4-mediated transcription. Oncogene 25, 4441-4448 (Pubitemid 44141632)
12. Valenta, T., Lukas, J., and Korinek, V. (2003) HMG box transcription factor TCF4 interaction with CtBP1 controls the expression of the Wnt target Axin2/Conductin in human embryonic kidney cells. Nucleic Acids Res. 31, 2369-2380 (Pubitemid 37442105)
13. Quinlan, K. G., Verger, A., Kwok, A., Lee, S. H., Perdomo, J., Nardini, M., Bolognesi, M., and Crossley, M. (2006) Role of the C-terminal binding protein PXDLS motif binding cleft in protein interactions and transcriptional repression. Mol. Cell. Biol. 26, 8202-8213 (Pubitemid 44631016)
14. Kufe, D. (2009) Mucins in cancer: Function, prognosis, and therapy. Nat. Rev. Cancer 9, 874-885
15. Kufe, D., Inghirami, G., Abe, M., Hayes, D., Justi-Wheeler, H., and Schlom, J. (1984) Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors. Hybridoma 3, 223-232 (Pubitemid 15184701)
16. Yamamoto, M., Bharti, A., Li, Y., and Kufe, D. (1997) Interaction of the DF3/MUC1 breast carcinoma-associated antigen and β-catenin in cell adhesion. J. Biol. Chem. 272, 12492-12494 (Pubitemid 27203339)
17. Huang, L., Ren, J., Chen, D., Li, Y., Kharbanda, S., and Kufe, D. (2003) MUC1 cytoplasmic domain coactivates Wnt target gene transcription and confers transformation. Cancer Biol. Ther. 2, 702-706
18. Huang, L., Chen, D., Liu, D., Yin, L., Kharbanda, S., and Kufe, D. (2005) MUC1 oncoprotein blocks glycogen synthase kinase 3β-mediated phosphorylation and degradation of β-catenin. Cancer Res. 65, 10413-10422 (Pubitemid 41743735)
19. Li, Y., Bharti, A., Chen, D., Gong, J., and Kufe, D. (1998) Interaction of glycogen synthase kinase 3β with the DF3/MUC1 carcinoma-associated antigen and β-catenin. Mol. Cell. Biol. 18, 7216-7224 (Pubitemid 28533041)
20. Schroeder, J. A., Adriance, M. C., Thompson, M. C., Camenisch, T. D., and Gendler, S. J. (2003) MUC1 alters β-catenin-dependent tumor formation and promotes cellular invasion. Oncogene 22, 1324-1332 (Pubitemid 36384593)
21. Raina, D., Ahmad, R., Joshi, M. D., Yin, L., Wu, Z., Kawano, T., Vasir, B., Avigan, D., Kharbanda, S., and Kufe, D. (2009) Direct targeting of the mucin 1 oncoprotein blocks survival and tumorigenicity of human breast carcinoma cells. Cancer Res. 69, 5133-5141
22. Leng, Y., Cao, C., Ren, J., Huang, L., Chen, D., Ito, M., and Kufe, D. (2007) Nuclear import of the MUC1-C oncoprotein is mediated by nucleoporin Nup62. J. Biol. Chem. 282, 19321-19330 (Pubitemid 47100108)
23. Ahmad, R., Raina, D., Joshi, M. D., Kawano, T., Ren, J., Kharbanda, S., and Kufe, D. (2009) MUC1-C oncoprotein functions as a direct activator of the nuclear factor-κB p65 transcription factor. Cancer Res. 69, 7013-7021
24. Ahmad, R., Rajabi, H., Kosugi, M., Joshi, M. D., Alam, M., Vasir, B., Kawano, T., Kharbanda, S., and Kufe, D. (2011) MUC1-C oncoprotein promotes STAT3 activation in an autoinductive regulatory loop. Science Signaling 4, ra9
25. Subramanian, T., and Chinnadurai, G. (2003) Association of class I histone deacetylases with transcriptional corepressor CtBP. FEBS Lett. 540, 255-258 (Pubitemid 36398067)
26. Brannon, M., Brown, J. D., Bates, R., Kimelman, D., and Moon, R. T. (1999) XCtBP is a XTcf-3 co-repressor with roles throughout Xenopus development. Development 126, 3159-3170 (Pubitemid 29378179)
27. Kioussi, C., Briata, P., Baek, S. H., Rose, D. W., Hamblet, N. S., Herman, T., Ohgi, K. A., Lin, C., Gleiberman, A., Wang, J., Brault, V., Ruiz-Lozano, P., Nguyen, H. D., Kemler, R., Glass, C. K., Wynshaw-Boris, A., and Rosenfeld, M. G. (2002) Identification of a Wnt/Dvl/β-Catenin→Pitx2 pathway mediating cell-type-specific proliferation during development. Cell 111, 673-685 (Pubitemid 35441249)
28. Evans, P. M., Chen, X., Zhang, W., and Liu, C. (2010) KLF4 interacts with β-catenin/TCF4 and blocks p300/CBP recruitment by β-catenin. Mol. Cell. Biol. 30, 372-381
29. Love, J. J., Li, X., Case, D. A., Giese, K., Grosschedl, R., and Wright, P. E. (1995) Structural basis forDNAbending by the architectural transcription factor LEF-1. Nature 376, 791-795
30. Duval, A., Rolland, S., Tubacher, E., Bui, H., Thomas, G., and Hamelin, R. (2000) The human T-cell transcription factor-4 gene: Structure, extensive characterization of alternative splicings, and mutational analysis in colorectal cancer cell lines. Cancer Res. 60, 3872-3879 (Pubitemid 32204580)
31. Arce, L., Yokoyama, N. N., and Waterman, M. L. (2006) Diversity of LEF/TCF action in development and disease. Oncogene 25, 7492-7504 (Pubitemid 44885748)
32. Weinberg, R. A. (1995) The retinoblastoma protein and cell cycle control. Cell 81, 323-330
33. Lamb, J., Ramaswamy, S., Ford, H. L., Contreras, B., Martinez, R. V., Kittrell, F. S., Zahnow, C. A., Patterson, N., Golub, T. R., and Ewen, M. E. (2003) A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer. Cell 114, 323-334 (Pubitemid 36962931)
34. Hatsell, S., Rowlands, T., Hiremath, M., and Cowin, P. (2003) β-Catenin and Tcfs in mammary development and cancer. J. Mammary Gland. Biol. Neoplasia 8, 145-158 (Pubitemid 38129938)
35. Yu, Q., Geng, Y., and Sicinski, P. (2001) Specific protection against breast cancers by cyclin D1 ablation. Nature 411, 1017-1021 (Pubitemid 32612319)
36. Landis, M. W., Pawlyk, B. S., Li, T., Sicinski, P., and Hinds, P. W. (2006) Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis. Cancer Cell 9, 13-22 (Pubitemid 43069507)
37. Jeselsohn, R., Brown, N. E., Arendt, L., Klebba, I., Hu, M. G., Kuperwasser, C., and Hinds, P. W. (2010) Cyclin D1 kinase activity is required for the self-renewal of mammary stem and progenitor cells that are targets of MMTV-ErbB2 tumorigenesis. Cancer Cell 17, 65-76
38. Dickson, C., Fantl, V., Gillett, C., Brookes, S., Bartek, J., Smith, R., Fisher, C., Barnes, D., and Peters, G. (1995) Amplification of chromosome band 11q13 and a role for cyclin D1 in human breast cancer. Cancer Lett. 90, 43-50
39. Bartkova, J., Lukas, J., Müller, H., Lützhøft, D., Strauss, M., and Bartek, J. (1994) Cyclin D1 protein expression and function in human breast cancer. Int. J. Cancer 57, 353-361 (Pubitemid 24168609)
40. Gillett, C., Fantl, V., Smith, R., Fisher, C., Bartek, J., Dickson, C., Barnes, D., and Peters, G. (1994) Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res. 54, 1812-1817 (Pubitemid 24116192)
41. McIntosh, G. G., Anderson, J. J., Milton, I., Steward, M., Parr, A. H., Thomas, M. D., Henry, J. A., Angus, B., Lennard, T. W., and Horne, C. H. (1995) Determination of the prognostic value of cyclin D1 overexpression in breast cancer. Oncogene 11, 885-891
42. Duraisamy, S., Kufe, T., Ramasamy, S., and Kufe, D. (2007) Evolution of the human MUC1 oncoprotein. Int. J. Oncol. 31, 671-677
43. Takahashi-Yanaga, F., and Sasaguri, T. (2008) GSK-3β regulates cyclin D1 expression: A new target for chemotherapy. Cell Signal 20, 581-589 (Pubitemid 351241128)
44. Jirawatnotai, S., Hu, Y., Michowski, W., Elias, J. E., Becks, L., Bienvenu, F., Zagozdzon, A., Goswami, T., Wang, Y. E., Clark, A. B., Kunkel, T. A., van Harn, T., Xia, B., Correll, M., Quackenbush, J., Livingston, D. M., Gygi, S. P., and Sicinski, P. (2011) A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers. Nature 474, 230-234